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Abstract Introduction Dysphagia is a common symptom in Parkinson’s disease (PD) and it has
been associated with poor quality of life (QoL), anxiety, depression.
Objective The aim of this study was to evaluate the quality of life in individuals with PD
before and after SLP therapy.
Methods The program consisted of four individual therapy sessions. Each session
comprised guidelines regarding food and postural maneuvers (chin down). The Quality
of Life in Swallowing Disorders (SWAL-QOL) questionnaire was applied before and after
therapy.
Results The sample comprised of 10 individuals (8 men), with a mean (SD) age of 62.2
(11.3) years, mean educational attainment of 7.5 (4.3) years, andmean disease duration
of 10.7 (4.7) years. Thirty percent of patients were Hoehn and Yahr (H&Y) stage 2, 50%
were H&Y stage 3, and 20% were H&Y stage 4. Mean scores for all SWAL-QOL domains
increased after the intervention period, with significant pre- to post-therapy differences
in total score (p ¼ 0.033) and domain 4 (symptom frequency) (p ¼ 0.025). There was
also a bias significance for domain 5 (food selection) (p ¼ 0.095).
Conclusion Patients exhibited improvement in swallowing-related quality of life after
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Dysphagia is a common symptom in Parkinson’s disease (PD)
and may occur at any stage in the disease course. It is
estimated that up to 80% of patients with early-stage PD
experience oropharyngeal dysphagia. At advanced stages, the
incidence may be as high as 95%.1–4 The main signs and
symptoms of dysphagia in PD are: delayed oral transit;
difficulties in bolus formation; residual food in the oral cavity;
poor bolus ejection; multiple swallows; posterior loss of
bolus; decreased swallowing reflex; alterations in vocal fold
closure; reduced pharyngeal and esophageal motility; pha-
ryngeal stasis; esophageal sphincter dysfunction; gastro-
esophageal reflux; laryngeal penetration; pulmonary
aspiration; oropharyngeal bradykinesia; reduced anterior
hyoid bone movement; and decreased epiglottis rotation
angle during swallowing.5–7 Furthermore, studies show
that pneumonia is the main cause of death in patients with
PD, demonstrating the importance of speech-language pa-
thologist (SLP)-based intervention for dysphagia to delay the
onset of this symptom.8,9
Within this context, a growing number of studies have
search to assess the efficacy and efficiency of therapeutic
interventions made by SLP for this signs and symptom of
dysphagia in PD, as described above.5,10–12 These studies have
demonstrated the benefits of several treatment strategies in
decreasing signs and symptoms of dysphagia and improving
swallow safety in patients with PD, including food consisten-
cy modification, thermal–tactile stimulation, and expiratory
muscle strength training (EMST).5,10–12
According to literature,6,13,14 patients with PD scored
lower in the SWAL-QOL survey, suggesting poor quality of
life. Furthermore, patients with more advanced disease
scored lower on the questionnaire. Thus, dysphagia has
been associated with poor quality of life (QoL), anxiety,
depression.
In the revised literature, we observed an absence of
national studies that ascertain the impact on QoL of SLP-
based intervention. Within this context, the present study
assess QoL in patients with PD before and after a speech-
language pathologist-led dysphagia therapy program.
Methods
This is a case-control study with subjects with Parkinson’s
disease. We selected participants from the Movement Dis-
orders Center at a reference hospital. The study received
approval from the Research Ethics Committee, registered
under number 140263. All subjects signed an informed
consent.
The inclusion criteria were a confirmed diagnosis of PD
and accept to take part of a therapy program involving one
session a week, during four consecutive weeks. The exclusion
criteria were patients with language and/or hearing impair-
ments that would prevent comprehension of the intervention
program and patients with dementia.
Before and after therapy, patients underwent assessments
which included the application of the SWAL-QOL tool. This
questionnaire comprises 44 items that assess 11 domains
(Burden; Eating desire; Feeding duration; Symptom frequen-
cy; Food selection; Communication; Fear; Mental health;
Social Function; Sleep; and Fatigue), which are scored on a
scale of 0 to 100. It is designed to ascertain the symptoms
experienced by patients and the influence of these symptoms
on QoL. The SWAL-QOL is an important tool for monitoring
the efficacy of rehabilitation from the patient’s point of view
by assessing swallowing-related QoL. We used the Brazilian
Portuguese validated version of the questionnaire.15
The questionnaire was administered in an examining
room and had an average duration of 20 minutes. The
investigator read the items and answer choices to each
patient, to minimize the effect of low education level and
the decrease in visual acuity, thus, ensuring a proper under-
standing of the questionnaire and minimizing misleading
answers due to the lack of understanding of the question-
naire. To avoid possible bias, we followed this procedure with
all individuals. Data collection took place from March to
August 2014.
Patients took part in a SLP intervention program, which
consisted of four individual therapy sessions with 30 minute
each, during which patients received guidelines regarding
food (►Table 1) and a postural maneuver (chin down). The
chin-down posture maneuver follows the recommendations
in the literature due to be easy to learn for the patient, as well
as its aim of reducing the early escape and possible food
intake in the airway.16–18
For statistical analysis, we conducted the Shapiro-Wilks
test to verify normality of the variables. The Wilcoxon test
was used to compare mean scores for each SWAL-QOL
domain before and after therapy (variables without asymme-
try distribution). The paired-samples Student t-test was used
for comparison of total SWAL-QOL scores before and after
therapy (variables with normal distribution). Spearman cor-
relation coefficients were used to correlate pre- and post-
therapy differences in each SWAL-QOL domain with the
variables age, Hoehn and Yahr (H&Y) stage, and educational
level (variables without normal distribution). We used the
Mann-Whitney Test to correlate pre- and post-therapy differ-
ences in each SWAL-QOL domain with the variable gender.
Analysis of covariance was used for analysis of total SWAL-
QOL scores in relation to the variables gender, age, and H&Y
stage. We assumed a 5% error rate for all tests. We performed
all analyses in SPSS 20.0.
Results
The study sample comprised 11 patients with PD. However,
one patient was excluded for failure to take part in all
sessions. The final sample comprised 10 participants. Of
these, 80% were male. The mean (SD) age was 62.2 (11.3)
years, the mean educational level was 7.5 (4.3) years, and the
mean disease durationwas 10.7 (4.7) years. Regardingdisease
stage, three patients (30%) were H&Y stage 2, five patients
(50%) were H&Y 3, and two patients (20%) were H&Y 4.
►Table 2 shows comparisons of scores for each SWAL-QOL
domain before and after the SLP therapy. The mean of all
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Table 1 Guidelines regarding food
Guidelines regarding food
Feeding environment:
- Take your meals in a quiet place.
- Turn off the TV, radio, or any other devices that may distract you while you are eating.
- Focus on eating.
- Do not talk while eating.
- Avoid taking meals when you feel sleepy or very tired.
- Try to take your meals during your “on” time.
Posture while feeding:
- Sit close to the table.
- Remain upright and hold your head up.
- Avoid lying down just after finishing your meal.
- Take small bites of food into your mouth.
- Chew food thoroughly.
- Swallow more than once, until you are sure no food remains in your mouth.
- If you feel there is food “stuck in your throat”, swallow saliva more often.
Meal duration:
- The maximum time for a major meal (breakfast, lunch, and dinner) should be 30 minutes;
- Do not rush through your meal.
Oral hygiene:
- Brush teeth thoroughly after your meals.
- Remember to brush your tongue.
- If you wear dentures, remove them and brush them clean after every meal. Remember to brush your tongue as well.
- Edentulous patients should brush their tongue and clean the rest of the oral cavity with a water-soaked gauze dressing and
antiseptic mouthwash.
Table 2 SWAL-QOL scores before and after Dysphagia therapy
SWAL-QOL Domain PRE POST p Uw
Mean SD Mean SD
1. Burden 77.5 14.44 82.5 30.73 0.258 1.131
2. Eating desire 79.15 19.35 82.49 24.67 0.527 0.632
3. Feeding duration 52.5 39.87 58.75 36.82 0.833 0.211
4. Symptom frequency 69.61 10.82 79.42 14.97 0.025 2.244
5. Food selection 65 26.87 86.25 28.53 0.095 1.667
6. Communication 42.5 23.71 55 31.84 0.103 1.630
7. Fear 66.87 25.69 76.87 29.47 0.260 1.127
8. Mental health 80.5 22.04 84 26.64 0.752 0.315
9. Social Function 71 28.06 83 26.58 0.116 1.572
10. Sleep 31.25 38.75 46.25 39.10 0.176 1.355
11. Fatigue 70.8 27.28 83.31 17.58 0.123 1.544
Total 64.24 29.65 74.34 30.49 0.033 0.672
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SWAL-QOL domains increased after the SLP intervention
period. However, the difference was only significant for the
Symptom Frequency domain (p ¼ 0.025 and r ¼ -2.24). In
addition, a significant difference in total scores was observed
after therapy (p ¼ 0.033).
The mean scores for each SWAL-QOL domain before and
after therapy were then tested for correlation with the
variables gender, H&Y stage, age and educational level, as
shown in ►Table 3. A significant correlation of domain Sleep
was observed with gender (p ¼ 0.047) and H&Y stage
(p ¼ 0.024 and r ¼ -0.74). Furthermore, the Food Selection
domain correlated significantly with H&Y stage (p ¼ 0.051
and r ¼ 0.66). In this way, the earlier stage of PD, the better
the improvement experienced in QoL after therapy.
In the assessment of swallowing, with regards to the signs
and symptoms of dysphagia, therewas a significant reduction
after SLP therapy for both consistencies, solid (p < 0.001) and
liquid (p ¼ 0.022).
Discussion
Although the literature1,2 reports the high incidence of
dysphagia in patients with PD,1,2 the influence of dysphagia
as a leading cause of death in PD,8,9 the silent aspirationwhich
reduces complaints,19 and its negative impact in QoL,13,20
there are still great difficulties in conducting studies with
rehabilitation. This is due to the absence of patient com-
plaints,17 and the difficulties of movement in patients with
PD, caused by postural instability, a characteristic symptomof
PD. These factors mean that few patients agree to participate
in this type of study, decreasing adherence to the therapeutic
process. In addition, SLP therapy is a continuous process,
which can be impaired due to clinical fluctuations of the
patient, such as worsening of motor symptoms.
Thus, few studies have investigated the influence of ther-
apy on swallowing-related QoL. In the literature review for
this article, we found only three studies,6,10,14 all of which
reported QoL and clinical improvement after SLP interven-
tion, regardless of the therapeutic technique used and the
number of sessions.
Data analysis showed that average scores for all SWAL-QOL
domains improved after the intervention period. However,
this differencewas only significant for the Symptom Frequen-
cy domain, providing evidence of a positive modification in
QoL regarding the frequency of symptoms. These findings
corroborate with the literature.6,14 In addition, there is a
positive change in the complaints, due to reduction in the
frequency of symptoms presented by the patients. Corrobo-
rating with Argolo et al,6 which found significant improve-
ment in Fear and Frequency of Symptoms domains.
In this study, we verified that the relation between QOL
and swallowing was moderate in the first assessment before
the therapy program, showing that dysphagia had a negative
effect on patient QoL. According to the study by Plowman-
Prine et al20 36 patients with and without dysphagia, with a
mean age 65.6 years (10.8) and disease duration 11.5 years
(0.5), and similar to our findings, patientswith PD evaluated
by SWAL-QOL exhibited moderate swallow-related QoL. In
addition, dysphagia had a negative impact on patient QoL;
total scores in the dysphagia group were lower than in the
non-dysphagia group.
Regarding swallowing-related complaints, the study found
positive impacts on QoL regardless of age, educational level, or
H&Y score; Disease stage was the only variable to interfere with
QoL. This corroborates with the existing literature,6 which
reports a reduction in swallow-related complaints after SLP
intervention. However, in both studies, the sample can be a
limiting factor, due to the significantly small sample size of 10
patients in this study and 15 patients in the literature. The
limited sample size in the present studywas due to the difficulty
of conducting a study therapy in PD individuals.
Thus, it is important to note the importance of dysphagia
therapy for this population, to reduce the complaints regard-
ing swallowing and provide an improvement in QoL of these
Table 3 Correlations of SWAL-QOL Domains with Gender, H&Y stage, age, and educational level
SWAL-QOL Domain Gendera H&Y Age Education
p r p r p r
1. Burden 0.506 0.203 0.469 1.0 0.000 0.772 0.106
2. Eating desire 0.224 0.792 0.103 0.627 0.176 0.174 0.467
3. Feeding duration 0.895 0.396 0.323 0.407 0.295 0.892 0.050
4. Symptom frequency 0.433 0.646 0.178 0.365 0.321 0.464 0.262
5. Food selection 0.694 0.051 0.665 0.542 0.220 0.331 0.344
6. Communication 0.143 0.807 0.096 0.892 0.049 0.523 0.230
7. Fear 0.147 0.560 0.226 0.134 0.508 0.086 0.569
8. Mental health 0.589 0.709 0.146 0.519 0.232 0.089 0.565
9. Social Function 0.893 0.444 0.293 0.379 0.313 0.890 0.050
10. Sleep 0.047 0.024 0.743 0.320 0.351 0.993 0.003
11. Fatigue 0.147 0.773 0.113 0.324 0.177 0.358 0.326
Total 0.554 0.858  0.936  0.543 
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patients. We verified that the therapeutic strategies used in
both studies are distinct, and yet the results resemble each
other. This finding suggests that SLP therapy regarding the
increased attention given to the feeding problem by the
patient may be the deciding factor for the success of the
therapeutic process. This is due the fact that silent aspiration
is a frequent clinical sign of dysphagia in patientswith PD. It is
known that the absence of the cough reflex limits the
possibility of dysphagia identification, which can cause a
decrease in the complaint and awareness of the problem by
patients.21,22
This finding demonstrates the importance of dysphagia
therapy in this population, as a way of reducing swallowing-
related complaints and improving QoL.
Our sample was predominantly composed by males, with
mean age of 62.2 (11.3) years, as in the previous studies of
Plowman-Prine et al20 and Argolo et al,6 in which the mean
age was  65.6 and  59.2 years, respectively. According to
the literature men have a higher estimated risk of developing
PD than women.23
Although the intervention applied in the present study
consisted of only four weekly sessions of therapy, versus five
weekly sessions in the Argolo et al6 study and 13 to 15
sessions in the Heijen et al14 study, we observed similar
outcomes in terms of QoL improvement. Therefore, the
number of therapy sessions does not seem to be a factor of
direct influence on the improvement of QOL in this popula-
tion. Furthermore, in studies from Troche et al,10 Argolo et al6
and Heijen et al,14 it was not used the same therapeutic
strategy, and yet, it was found in all studies a improvement of
QOL in the patients. Tis way, it also verifies the diversity of SLP
treatment strategies for improvement of QOL related to
swallowing, in individuals with PD.
Conclusion
Our results suggest that swallowing-related QoL improved
after a SLP intervention. The early stage of PD, the greater the
improvement experienced after therapy. This demonstrates
that the earlier start SLP intervention better will be the effects
on quality of life. We observed positive modifications in
dysphagia-related complaints regardless of gender, age, edu-
cational level, and H&Y stage. Thus, disease stagewas the only
variable found to interfere with QoL.
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